MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


Animalcare acquires Randlab for £62.2 million using new funds raised

ALN

Animalcare Group PLC on Tuesday said it had entered into a conditional agreement to acquire Randlab Australia Pty Ltd for around £62.2 million in part using proceeds from fundraising announced today.

Animalcare is a York, England-based supplier of veterinary pharmaceutical products. It said Randlab is an Australian-based equine veterinary business.

The acquisition will be funded through Animalcare’s existing cash resources, committed debt facilities and a new equity placing through an accelerated bookbuild process launched on Tuesday.

Animalcare raised £20 million before expenses through an oversubscribed placing and subscription. The company placed around 8.6 million shares at a price of 232.50 pence per placing share.

The share price represents a discount of 5.1% to Monday’s last closing price of 245.00 pence.

The company said its largest shareholder, Alychlo NV, participated for 10% of the fundraise.

Animalcare said it expects the acquisition to be materially earnings accretive, by at least 20% in financial 2025.

Chief Executive Jenny Winter said: ‘We are delighted to have reached an agreement to acquire Randlab subject to completion of the transaction. This is a highly attractive opportunity to acquire a market-leading equine asset in Australia that is expected to deliver significant earnings accretion in 2025.

‘This is a transformational deal that provides an excellent fit with our growth strategy and is complementary to our product portfolio...Not only will this acquisition significantly elevate the group’s offering in a growing equine market, it will also open wider opportunities in a commercially and regulatorily aligned business environment,’ she said.

On the fundraise, Winter said: ‘We are delighted to announce today’s successful fundraise of £20 million...The net proceeds of the fundraise will be used to part fund the acquisition of Randlab - a transformational deal that provides an excellent fit with our growth strategy and is complementary to our product portfolio.’

Shares in Animalcare were down 0.7% to 243.25 pence in London on Tuesday afternoon.

Copyright 2024 Alliance News Ltd. All Rights Reserved.